In a win for pharmacy in the decade long squirmish between FDA and compounding pharmacies, FDA has been ordered to conduct a review of its MOU. The MOU establishes an understanding between individual State Boards of Pharmacy and the FDA involving... Read More
Articles | Community, Retail Pharmacies | Life Sciences | National Board of Pharmacy Matters | Pharmacy Law | Physician Dispensing

Worldwide there are fewer than 500,000 people with hemophilia, a genetic disease that inhibits a patient’s blood clotting ability. Hemophilia is caused by genetic mutations in a patient and is hereditary, meaning that the condition is often passed... Read More
Articles | Community, Retail Pharmacies | Employment Matters | Life Sciences | National Board of Pharmacy Matters | Pharmacy Law | Pharmacy Transactions | Value Based Care | White Collar Criminal Defense & Government Investigations

Question: What could be worse than a PBM audit? Answer: A PBM audit coupled with a State Board of Pharmacy investigation. As we have written on previously, Frier Levitt is witnessing an uptick in PBM-initiated complaints to State Boards of... Read More
Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | National Board of Pharmacy Matters

In recent years we have seen an increase in Board of Pharmacy investigations and complaints tied to inventory maintenance, and more specifically, inventory shortfalls between what the pharmacy has purchased from their wholesalers, and what has been... Read More
Articles | Life Sciences | National Board of Pharmacy Matters | Pharmacy Law

Frier Levitt has noticed an increasing trend in State Board of Pharmacy investigations being commenced that closely mimic audit findings issued by Pharmacy Benefit Managers (“PBMs”).  These Board of Pharmacy investigations place additional... Read More
Articles | Life Sciences | National Board of Pharmacy Matters | Pharmacy Law